Showing results (641-650 of 654) with videos related to
Sort By:
Pageof 66
The Journal of Infectious Diseases|November 29, 2024
Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational StudyHyun Myung Kang, Hye-Jin Kim, Jiwon Jung, et al.American Journal of Respiratory and Critical Care Medicine|June 16, 2012
Viral infection in patients with severe pneumonia requiring intensive care unit admissionSang-Ho Choi, Sang-Bum Hong, Gwang-Beom Ko, et al.Plos Neglected Tropical Diseases|December 30, 2016
Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013-2015Seong Jin Choi, Sang-Won Park, In-Gyu Bae, et al.Journal of Korean Medical Science|July 21, 2020
Psychological Impact of Quarantine on Caregivers at a Children's Hospital for Contact with Case of COVID-19Harin Kim, Kee Jeong Park, Yong Wook Shin, et al.Immunity & Ageing : I & A|July 31, 2024
Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profilingZayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, et al.Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.Microbiology Spectrum|October 17, 2022
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainBeomki Lee, Jae-Hoon Ko, Kyoung Hwa Lee, et al.Cell Reports. Medicine|August 1, 2025
Proteogenomic characterization unveils biomarkers associated with chemoresistance in muscle-invasive bladder cancerMatthew V Holt, Yongchao Dou, Meggie N Young, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.Frontiers in Immunology|October 10, 2022
Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South KoreaEliel Nham, Jae-Hoon Ko, Kyoung-Ho Song, et al.Pageof 66